Global High Flow Nasal Cannula Market Size Likely to Reach at a CAGR of 5.4% By 2034
Key highlights
- According to industry experts at CMI, High Flow nasal cannula (HFNC) is a non-invasive respiratory support system where heated, humidified oxygen is delivered at high flow rates using a nasal cannula.
- Growing geriatric population The growing geriatric population is a major driving factor for the high-flow nasal cannula (HFNC) market.
- As stresses on the global healthcare systems, including a rise in patient count and a spectrum of respiratory discomfort cases, continue to mount, the demand for HFNC devices has been rising.
- [ij_bar_charts reportid="68703"] Growing geriatric population The growing geriatric population is a major driving factor for the high-flow nasal cannula (HFNC) market.
High Flow Nasal Cannula Market Size
As per the current market research conducted by the CMI Team, the Global High Flow Nasal Cannula Market size is expected to record a CAGR of 5.4% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 3.7 billion. By 2034, the valuation is anticipated to reach USD 5.9 billion.
High Flow Nasal Cannula Market Overview
According to industry experts at CMI, High Flow nasal cannula (HFNC) is a non-invasive respiratory support system where heated, humidified oxygen is delivered at high flow rates using a nasal cannula. In pediatric care environments and for individuals with either abrupt respiratory failure or chronic obstructive pulmonary disease (COPD), HFNC is especially crucial.
Its primary application is in a range of healthcare environments, including home healthcare environments, emergency departments, and intensive care units (ICUs). As stresses on the global healthcare systems, including a rise in patient count and a spectrum of respiratory discomfort cases, continue to mount, the demand for HFNC devices has been rising.
Source: Custom Market Insights analysis.
The key drivers of this market are technological improvements, increasing awareness and acceptance rates among medical specialists, and the higher sensitivity of the aging population to respiratory diseases. Emerging markets show the most recent probable opportunities in this sector since awareness campaigns can boost usage and healthcare infrastructure is developing there.
High Flow Nasal Cannula Market Growth Factors and Dynamics
Growing geriatric population
The growing geriatric population is a major driving factor for the high-flow nasal cannula (HFNC) market. Since chronic obstructive pulmonary disease (COPD) and other respiratory diseases are more common in this age group, which makes HNFC an attractive option.
Furthermore, the older population is increasingly inclining towards non-invasive respiratory support techniques. For instance, 80% of older people will reside in developing areas by 2050, as per the World Health Organization.
Advancement in technology
The High Flow Nasal Cannulas (HFNC) market is expanding rapidly because of the technological development. Presently, HFNC devices are safer, more effective, and simpler to use, which fuels their use in clinical settings.
To maintain proper moisture and temperature levels, modern HFNC systems employ sophisticated humidification procedures that enhance patient comfort and reduce airway discomfort. Also, touch-screen controllers and user-friendly interfaces have also helped medical professionals operating equipment by enabling precise monitoring and adjustments. Thereby driving the market growth.
Limited awareness and training
Healthcare practitioners' ignorance and lack of training significantly hampered the high-flow nasal cannula (HFNC) market, especially in developing regions. Many healthcare professionals' insufficient awareness of the characteristics and benefits of HFNC devices causes underutilization and slower market penetration. Moreover, effective usage of HFNC devices depends on certain training.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 3.7 Billion |
| Projected Market Size in 2034 | USD 5.9 Billion |
| Market Size in 2024 | USD 3.5 Billion |
| CAGR Growth Rate | 5.4% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product Type, Application, End User, Sales Channel and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
List of the prominent players in the High Flow Nasal Cannula Market:
- Vapotherm Inc.
- Armstrong Medical Ltd
- Salter Labs Inc
- ResMed Inc.
- Teleflex Inc
- BD
- Smiths Medical
- Flexicare Medical Ltd
- Teijin Pharma Limited
- TNI Medical AG
- Fisher & Paykel Healthcare Limited
- Hamilton Medical AG
- Drägerwerk AG & Co. KGaA
- Heka Medicals India Pvt Ltd.
- GaleMed Corporation
- Others
The High Flow Nasal Cannula Market is segmented as follows:
By Product Type
- Single Heated Tube
- Nasal Cannula
- Active Humidifier
- Air Blender
By Application
- Acute Respiratory Failure
- Chronic Obstructive Pulmonary Disease
- Acute Heart Failure
- Others
By End User
- Hospitals and Clinics
- Ambulatory Care Centers
- Long-term Care Centers
- Others
By Sales Channel
- Direct Channel
- Indirect Channel
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Rushikesh Dorge
View profile and reportsAbout Custom Market Insights
Custom Market Insights is a market research and advisory company. It publishes syndicated reports across 18+ industries and delivers custom research, feasibility studies and market entry strategy for companies, investors and consultancies.
###